Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 929

2'-fucosyllactose

Intended Use: Intended for use as an ingredient in exempt hypoallergenic infant formula for term infants and hypoallergenic toddler formula at a level of 2 g/L of formula, as consumed. The notifier states that hypoallergenic formula includes both extensively hydrolyzed cow milk protein- and amino acid-based formula.
Basis: Scientific procedures
Notifier: Jennewein Biotechnologie GmbH
Notifier Address: Maarweg 32
D-53619 Reinbreitbach
GERMANY
GRAS Notice (releasable information): GRN 929 (in PDF) (4.2 MB)
  Part 2: GRN 929 amendments (7.1 MB)
Date of closure: Feb 26, 2021
FDA's Letter: FDA has no questions (267 kB)
-
-